EGFR- and HER3-targeted bispecific antibody-drug conjugate demonstrates antitumor activity in metastatic castration-resistant prostate cancer
- DOI
- 10.1172/jci201090
- Published
- 2026-04-07
- Container
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci201090,
title = {EGFR- and HER3-targeted bispecific antibody-drug conjugate demonstrates antitumor activity in metastatic castration-resistant prostate cancer},
author = {Bangwei Fang and Xiaomeng Li and Ying Lu and Weiwei Ma and Hualei Gan and Tingwei Zhang and Qi Liu and Beihe Wang and Zixian Wang and Yi Zhu and Hai Zhu and Sa Xiao and Xiaojie Bian and Gonghong Wei and Dingwei Ye and Yao Zhu},
year = {2026},
journal = {Journal of Clinical Investigation},
doi = {10.1172/jci201090},
url = {https://doi.org/10.1172/jci201090}
}RIS
TY - JOUR TI - EGFR- and HER3-targeted bispecific antibody-drug conjugate demonstrates antitumor activity in metastatic castration-resistant prostate cancer AU - Bangwei Fang AU - Xiaomeng Li AU - Ying Lu AU - Weiwei Ma AU - Hualei Gan AU - Tingwei Zhang AU - Qi Liu AU - Beihe Wang AU - Zixian Wang AU - Yi Zhu AU - Hai Zhu AU - Sa Xiao AU - Xiaojie Bian AU - Gonghong Wei AU - Dingwei Ye AU - Yao Zhu PY - 2026 JO - Journal of Clinical Investigation DO - 10.1172/jci201090 UR - https://doi.org/10.1172/jci201090 ER -
APA
Fang, B., Li, X., Lu, Y., Ma, W., Gan, H., Zhang, T., Liu, Q., Wang, B., Wang, Z., Zhu, Y., Zhu, H., Xiao, S., Bian, X., Wei, G., Ye, D., & Zhu, Y. (2026). EGFR- and HER3-targeted bispecific antibody-drug conjugate demonstrates antitumor activity in metastatic castration-resistant prostate cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci201090
Source records
- crossref · retrieved 2026-09-27T08:44:02.162Z